Our Team
At the core of Medicenna is a team with decades of experience creating medicines and creating value, with a passion for cutting-edge science and developing medicines for patients with the highest unmet needs.
Management Team
Leading with vision and expertise
Fahar Merchant, PhD
President and Chief Executive Officer"Dr. Merchant is a biotech veteran with 30 years of experience as a serial entrepreneur and co-founder of Medicenna. Previously he was President and CEO of Protox Therapeutics Inc. where he transitioned a pre-clinical sta..."
Dr. Nageatte Ibrahim, M.D.
Chief Medical Officer"Dr. Nageatte Ibrahim is Chief Medical Officer of Medicenna Therapeutics. She most recently served as Chief Medical Officer of Oncology at Innovent Biologics USA, where she led a global clinical development team and playe..."
David Hyman, CA, CBV
Chief Financial Officer"David Hyman is a Chartered Accountant and Chartered Business Valuator with over 25 years of financial experience spanning public practice, capital markets, private equity, and industry. Mr. Hyman is a Partner with Tandem..."
Rosemina Merchant, MESc
Chief Development Officer"Ms. Merchant has over 30 years of experience in the development of biopharmaceuticals. Prior to co-founding Medicenna, Ms. Merchant was Senior VP of Development and Regulatory Affairs at Protox Therapeutics, Inc (TSX), a..."
John Mayfield, PhD
Chief Business Advisor"Dr. Mayfield is Chief Business Advisor, leveraging his expertise in licensing, transactions, and establishing strategic collaborations for Medicenna's innovative pipeline within the biotechnology and pharmaceutical compa..."
Dr. Arash Yavari, BSc, MBBS, DPhil
Director of Clinical Strategy"Dr. Arash Yavari is a physician-scientist with over 20 years of broad clinical, scientific and industry drug development experience. He has extensive expertise in early clinical development and scientific strategy across..."
Melissa Coello, BSc
VP, Clinical Operations"Melissa Coello is Vice President of Clinical Operations at Medicenna Therapeutics and brings extensive experience leading complex global clinical development programs in oncology and immunotherapy. She has deep expertise..."
Minh To, PhD
VP, Translational Sciences"Minh D. To has more than a decade of biotechnology industry experience in oncology and immuno-oncology. At Medicenna Therapeutics, he leads translational sciences and preclinical strategy supporting the advancement of th..."